Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03204981 · ClinicalTrials.gov registry record · NA
Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias
A NA study, sponsored by Vivek Reddy.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT03204981 is a NA study that has completed, run by Vivek Reddy. The registered enrollment target is 52 participants.
The verdict
NCT03204981, a NA study, has completed, sponsored by Vivek Reddy.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study will examine the safety and efficacy of intramural needle ablation (INA) in the treatment of intramural ventricular arrhythmias in patients for whom standard RF ablation has been unsuccessful. The clinical team hypothesize that the increased current density and improved rates of transmural lesion creation seen with intramural needle ablation will lead to successful arrhythmia termination with minimal or no increased risk of complication.
Interventions
- PROCEDURE Ablation
- DEVICE Intramural Needle Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2017-10-17 |
| Est. Completion | 2021-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03204981
The ClinicalTrials.gov registry entry for NCT03204981 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ablation is the first listed.
NCT03204981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03204981 about?
NCT03204981 is a clinical study titled "Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias". This study will examine the safety and efficacy of intramural needle ablation (INA) in the treatment of intramural ventricular arrhythmias in patients for whom standard RF ablation has been unsuccessful. The clinical team hypothesize that the increased current density and improved rates of transmura...
What is the current status of trial NCT03204981?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2017-10-17. Estimated completion is 2021-04-20.
What interventions are being tested in trial NCT03204981?
The interventions under investigation include: Ablation (PROCEDURE), Intramural Needle Ablation (DEVICE).
Who is sponsoring clinical trial NCT03204981?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.